QA: Affymax INC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001158223_2012_Affymax_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001158223, Affymax INC

  xvar xval
0 AssetsCurrent 107,620,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,013,000
3 remainder_Assets 8,362,000
4 LiabilitiesCurrent 19,766,000
5 LiabilitiesNoncurrent 1,526,000
6 remainder_Liabilities 21,706,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 32,818,000
9 ResearchAndDevelopmentExpense 76,308,000
10 remainder_Expenses 145,000
11 remainder_Revenues 47,720,000
12 remainder_NetIncome 184,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 118,995,000
1 Liabilities 42,998,000
2 Expenses 109,271,000
3 Revenues 47,720,000
4 StockholdersEquity 75,997,000
5 NetIncome -61,367,000
6 ComprehensiveNetIncome -61,367,000
7 BaseVar 159,584,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.29
9 EconomicCapitalRatio 2.52

Edgar->Model Mapping

Feature Distribution